Single high-dose dexamethasone and sodium salicylate failed to attenuate phosgene-induced acute lung injury in rats

Toxicology

Volumn 315, Issue 1, 2014, Pages 17-23

  Liu, Fangfang ^a,b   Pauluhn, Jürgen ^b   Trübel, Hubert ^b   Wang, Chen ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BAYER PHARMA AG   (Germany)

^c BEIJING HOSPITAL   (China)

Author keywords

Acute lung injury; Dexamethasone; Exhaled nitric oxide; Lung edema; Phosgene; Sodium salicylate

Indexed keywords

AMINOGUANIDINE; DEXAMETHASONE; NITRIC OXIDE; PHOSGENE; SALICYLATE SODIUM;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; EXPIRED AIR; INJURY SEVERITY; LUNG EDEMA; LUNG TOXICITY; LUNG WEIGHT; MALE; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

EID: 84890246239     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.11.005     Document Type: Article

References (41)

1. Baltazar M.T., Dinis-Oliveira R.J., Duarte J.A., Bastos M.L., Carvalho F. Antioxidant properties and associated mechanisms of salicylates. Curr. Med. Chem. 2011, 18:3252-3364.
2. Berthiaume Y., Lesur O., Dagenais A. Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium. Thorax 1999, 54:150-160.
3. Berthiaume Y., Folkesson H.G., Matthay M.A. Lung edema clearance: 20 years of progress - invited review: alveolar edema fluid clearance in the injured lung. J. Appl. Physiol. 2002, 93:2207-2213.
4. Berthiaume Y., Matthay M.A. Alveolar edema fluid clearance and acute lung injury. Respir. Physiol. Neurobiol. 2007, 159:350-359.
5. Brown R.F.R., Jugg B.J.A., Harban F.M.J., Ashley Z., Kenward C.E., Platt K.J., Hill A., Rice P., Watkins P.E. Pathophysiological responses following phosgene exposure in the anaesthetized pig. J. Appl. Toxicol. 2002, 22:263-269.
6. Bruner H.D., Gibbon M.H., McCarthy M.D., Boche R.D., Talbot T.R., Lockwood J.S., Sanders G.B. Studies on experimental phosgene poisoning; infusions in the treatment of experimental phosgene poisoning. Ann. Intern. Med. 1948, 28:1125-1131.
7. Chen J., Mo Y., Schlueter C.F., Hoyle G.W. Inhibition of chlorine-induced pulmonary inflammation and edema by mometasone and budenoside. Toxicol. Appl. Pharmacol. 2013, 408-413.
8. de Lange D.W., Meulenbelt J. Do corticosteroids have a role in preventing or reducing acute toxic lung injury caused by inhalation of chemical agents?. Clin. Toxicol. (Phila) 2011, 49:61-71.
9. Diller W.F. The methenamine misunderstanding in the therapy of phosgene poisoning. Arch. Toxicol. 1980, 46:199-206.
10. Diller E.F. Pathogenesis of phosgene poisoning. Toxicol. Ind. Health 1985, 7-15.
11. Dinis-Oliveira R.J., Duarte J.A., Remião F., Sánchez-Navarro A., Bastos M.L., Carvalho F. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology 2006, 227:73-85.
12. Dinis-Oliveira R.J., Remião F., Duarte J.A., Sánchez-Navarro A., Bastos M.L., Carvalho F. Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology 2006, 27:1110-1122.
13. Dinis-Oliveira R.J., Sousa .C., Remiao F., Duarte J.A., Navarro A.S., Bastos M.L., Carvalho F. Full survival of paraquat-exposed rats after treatment with sodium salicylate. Free Radic. Biol. Med. 2007, 42:1017-1028.
14. Dinis-Oliveira R.J., Sousa C., Remião F., Duarte J.A., Ferreira R., Sánchez, Navarro A., Bast M.L., Carvalho F. Sodium salicylate prevents paraquat-induced apoptosis in the rat lung. Free Radic. Biol. Med. 2007, 43:48-61.
15. Directive 86/609/EEC Guideline of the council dated November 24, 1986 on the reconciliation of legal and administrative regulations of the member countries for the protection of animals used for studies and other scientific purposes. J. Eur. Commun. 1986, 29:1-28. Legal Specifications L358.
16. Duniho S.M., Martin J., Forster J.S., Cascio M.B., Moran T.S., Carpin L.B., Sciuto A.M. Acute changes in lung histopathology and bronchoalveolar lavage parameters in mice exposed to the choking agent gas phosgene. Toxicol. Pathol. 2002, 30:339-349.
17. Grainge C., Rice P. Management of phosgene-induced acute lung injury. Clin. Toxicol. (Phila) 2010, 48:497-508.
18. Grainge C., Jugg B.J., Smith A.J., Brown R.F., Jenner J., Parkhouse D.A., Rice P. Delayed low-dose supplemental oxygen improves survival following phosgene-induced acute lung injury. Inhal. Toxicol. 2010, 22:552-560.
19. Igarashi J., Hashimoto T., Shoji K., Yoneda K., Tsukamoto I., Moriue T., Kubota Y., Kosaka H. Dexamethasone induces caveolin-1 in vascular endothelial cells: implications for attenuated responses to VEGF. Am. J. Physiol. Cell Physiol. 2013, 304:C790-C800.
20. Li W.-L., Hai C.X., Pauluhn J. Inhaled nitric oxide aggravates phosgene model of acute lung injury. Inhal. Toxicol. 2011, 23:842-851.
21. Li W.L., Liu F.F., Wang C., Truebel H., Pauluhn J. Novel insights into phosgene induced acute lung injury in rats: role of dysregulated cardiopulmonary reflexes and nitric oxide in lung edema pathogenesis. Toxicol. Sci. 2013, 131:612-628.
22. Liu F.F., Li W.L., Pauluhn J., Trübel H., Wang C. Rat models of acute lung injury: exhaled nitric oxide as a sensitive, noninvasive real-time biomarker of prognosis and efficacy of intervention. Toxicology 2013, 310C:104-114.
23. Matthay M.A., Clerici C., Saumon G. Lung edema clearance: 20 years of progress. invited reviews: active fluid clearance from the distal air spaces of the lung. J. Appl. Physiol. 2002, 93:1533-1541.
24. Matthay M.A., Folkesson H.G., Clerici C. Lung epithelial fluid transport and resolution of pulmonary edema. Physiol. Rev. 2002, 82:569-600.
25. McFadden E.R. Dosages of corticosteroids in asthma. Am. Rev. Respir. Dis. 1993, 147:1306-1310.
26. OECD Organization for Economic Cooperation and Development (OECD) - Environment, Health and Safety Publications. Series on Testing and Assessment No. 39: Guidance Document for Acute Inhalation Toxicity Testing, (ENV/JM/MONO 28; July 21, 2009) 2009.
27. Parkhouse D.A., Brown R.F., Jugg B.J., Harban F.M., Platt J., Kenward C.E., Jenner J., Rice P., Smith A.J. Protective ventilation strategies in the management of phosgene-induced acute lung injury. Mil. Med. 2007, 172:295-300.
28. Pauluhn J. Acute nose-only exposure of rats to phosgene. Part I: concentration×time dependence of LC50s and non-lethal-threshold concentrations and analysis of breathing patterns. Inhal. Toxicol. 2006, 18:423-435.
29. Pauluhn J. Acute nose-only exposure of rats to phosgene. Part II: concentration×time dependence of changes in bronchoalveolar lavage during a follow-up period of 3 months. Inhal. Toxicol. 2006, 18:595-607.
30. Pauluhn J., Hai C.X. Attempts to counteract phosgene-induced acute lung injury by instant high-dose aerosol exposure to hexamethylenetetramine, cysteine or glutathione. Inhal. Toxicol. 2011, 23:58-64.
31. Pauluhn J., Carson A., Costa D.L., Gordon T., Kodavanti U., Last J.A., Matthay M.A., Pinkerton K.E., Sciuto A.M. Workshop summary - phosgene-induced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animals models with emphasis on human significance. Inhal. Toxicol. 2007, 19:789-810.
32. Perretti M., D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 2009, 9:62-70.
33. Radi R., Cassina A., Hodara R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol. Chem. 2002, 383:401-409.
34. Riess U., Tegtbur U., Fauck C., Fuhrmann F., Markewitz D., Salthammer T. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in human exhaled breath. Anal. Chim. Acta 2010, 669:53-62.
35. Sartori C., Matthay M.A. Alveolar epithelial fluid transport in acute lung injury: new insights. Eur. Respir. J. 2002, 20:1299-1313.
36. Sciuto A.M., Strickland P.T., Kennedy T.P., Gurtner G.H. Postexposure treatment with aminophylline protects against phosgene-induced acute lung injury. Exp. Lung Res. 1997, 23:317-332.
37. Sciuto A.M., Strickland P.T., Kennedy T.P., Gurtner G.H. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am. J. Respir. Crit. Care Med. 1995, 151:768-772.
38. Sciuto A.M., Strickland P.T., Kennedy T.P., Guo Y.-L., Gurtner G.H. Intratracheal administration of DBcAMP attenuates edema formation in phosgene-induced acute pulmonary injury. J. Appl. Physiol. 1996, 80:149-157.
39. Sciuto A.M., Hurt H.H. Therapeutic treatments of phosgene-induced lung injury. Inhal. Toxicol. 2004, 16:565-580.
40. Ware L.B., Fremont R.D., Bastarache J.A., Calfee C.S., Matthay M.A. Determining the aetiology of pulmonary oedema by the oedema fluid-to-plasma protein ratio. Eur. Respir. J. 2010, 35:331-337.
41. Yeh D.Y.H., Feng N.H., Chen C.F., Lin H.I., Wang D. Inducible nitric oxide synthetase expressions in different lung injury models and the protective effect of aminoguianidine. Transplant. Proc. 2008, 40:2178-2181.